Sam Brusco, Associate Editor12.07.23
Wenzel Spine has appointed Dr. Charles R. Gordon as the new executive chairman of the company’s board of directors, expanding its leadership team.
Dr. Gordon was the founding chairman of the board for Baylor Scott & White's Texas Spine & Joint Hospital. He’s still active in medical practice.
"I am thrilled to join the Wenzel Spine executive leadership team," said Dr. Gordon. "I believe my extensive experience and proven track record in the industry will be invaluable as we continue to grow and innovate in the field of spine care. I think Wenzel Spine has the capability to quickly enter the minimally invasive interventional spine market with unique technologies."
The company said the strategic hire poises it to enhance the company’s edge into the minimally invasive interventional spine market. Wenzel has also engaged with boutique investment bank MM Dillon and Co., to help with strategic options for the company, including raising capital.
"The addition of Dr. Gordon to our executive team and our engagement with MM Dillon & Co. represent significant steps forward for Wenzel Spine, said Wenzel CEO William Willson. “We are confident that these strategic moves will enhance our ability to deliver innovative and effective spine solutions addressing our entry into MI interventional spine for our clients, partners and their patients."
Dr. Gordon was the founding chairman of the board for Baylor Scott & White's Texas Spine & Joint Hospital. He’s still active in medical practice.
"I am thrilled to join the Wenzel Spine executive leadership team," said Dr. Gordon. "I believe my extensive experience and proven track record in the industry will be invaluable as we continue to grow and innovate in the field of spine care. I think Wenzel Spine has the capability to quickly enter the minimally invasive interventional spine market with unique technologies."
The company said the strategic hire poises it to enhance the company’s edge into the minimally invasive interventional spine market. Wenzel has also engaged with boutique investment bank MM Dillon and Co., to help with strategic options for the company, including raising capital.
"The addition of Dr. Gordon to our executive team and our engagement with MM Dillon & Co. represent significant steps forward for Wenzel Spine, said Wenzel CEO William Willson. “We are confident that these strategic moves will enhance our ability to deliver innovative and effective spine solutions addressing our entry into MI interventional spine for our clients, partners and their patients."